Information Provided By: 
Fly News Breaks for March 5, 2020
SPLK
Mar 5, 2020 | 08:34 EDT
Needham analyst Jack Andrews raised the firm's price target on Splunk to $181 from $160 and keeps a Buy rating on the shares. The analyst notes that all of the company's Q4 key metrics exceeded consensus estimates, and while its FY21 guidance was meaningfully below consensus, the undershoot was solely due to a faster than expected ramp of its cloud revenue. Andrews adds that Splunk's software bookings and ARR growth should continue to be strong.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
